Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo

David T. Woodley, Douglas R. Keene, Tom Atha, Yi Huang, Ramin Ram, Noriyuki Kasahara, Mei Chen

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechanobullous disorders caused by mutations in the gene, COL7A1, that codes for type VII, (anchoring fibril), collagen, which is critical for epidermal-dermal adherence. Most gene therapy approaches have been ex vivo, involving cell culture and culture graft transplantation, which is logistically difficult. To develop a more simplified approach, we engineered a self-inactivating lentiviral vector expressing human type VII collagen and injected this vector intradermally into hairless, immunodeficient mice and into a human DEB composite skin equivalent grafted onto immunodeficient mice. In both situations, the vector transduced dermal cells, which in turn synthesized and exported type VII collagen into the extracellular space. Remarkably, the type VII collagen selectively adhered to and incorporated into the basement membrane zone (BMZ) between the dermis and the epidermis, where it formed anchoring fibril structures. In the case of the DEB skin equivalent, the newly expressed type VII collagen reversed the DEB phenotype characterized by poor epidermal-dermal adherence and anchoring fibril defects. A single lentiviral vector injection provided stable type VII collagen at the BMZ for at least 3 months. These data demonstrate efficient and long-term type VII collagen gene transfer in vivo using direct intradermal injection of an engineered lentiviral vector.

Original languageEnglish (US)
Pages (from-to)318-326
Number of pages9
JournalMolecular Therapy
Volume10
Issue number2
DOIs
StatePublished - Aug 2004
Externally publishedYes

Fingerprint

Collagen Type VII
Epidermolysis Bullosa Dystrophica
Intradermal Injections
Skin
Basement Membrane
Hairless Mouse
Extracellular Space
Dermis
Epidermis
Genetic Therapy
Genes
Collagen
Cell Culture Techniques
Transplantation
Transplants
Phenotype
Mutation
Injections

Keywords

  • Anchoring fibril
  • Basement membrane zone
  • Gene therapy
  • Lentivirus
  • Type VII colagen

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo. / Woodley, David T.; Keene, Douglas R.; Atha, Tom; Huang, Yi; Ram, Ramin; Kasahara, Noriyuki; Chen, Mei.

In: Molecular Therapy, Vol. 10, No. 2, 08.2004, p. 318-326.

Research output: Contribution to journalArticle

Woodley, David T. ; Keene, Douglas R. ; Atha, Tom ; Huang, Yi ; Ram, Ramin ; Kasahara, Noriyuki ; Chen, Mei. / Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo. In: Molecular Therapy. 2004 ; Vol. 10, No. 2. pp. 318-326.
@article{d16fa3a090a94afa9cc8fb63b984b412,
title = "Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo",
abstract = "Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechanobullous disorders caused by mutations in the gene, COL7A1, that codes for type VII, (anchoring fibril), collagen, which is critical for epidermal-dermal adherence. Most gene therapy approaches have been ex vivo, involving cell culture and culture graft transplantation, which is logistically difficult. To develop a more simplified approach, we engineered a self-inactivating lentiviral vector expressing human type VII collagen and injected this vector intradermally into hairless, immunodeficient mice and into a human DEB composite skin equivalent grafted onto immunodeficient mice. In both situations, the vector transduced dermal cells, which in turn synthesized and exported type VII collagen into the extracellular space. Remarkably, the type VII collagen selectively adhered to and incorporated into the basement membrane zone (BMZ) between the dermis and the epidermis, where it formed anchoring fibril structures. In the case of the DEB skin equivalent, the newly expressed type VII collagen reversed the DEB phenotype characterized by poor epidermal-dermal adherence and anchoring fibril defects. A single lentiviral vector injection provided stable type VII collagen at the BMZ for at least 3 months. These data demonstrate efficient and long-term type VII collagen gene transfer in vivo using direct intradermal injection of an engineered lentiviral vector.",
keywords = "Anchoring fibril, Basement membrane zone, Gene therapy, Lentivirus, Type VII colagen",
author = "Woodley, {David T.} and Keene, {Douglas R.} and Tom Atha and Yi Huang and Ramin Ram and Noriyuki Kasahara and Mei Chen",
year = "2004",
month = "8",
doi = "10.1016/j.ymthe.2004.05.016",
language = "English (US)",
volume = "10",
pages = "318--326",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo

AU - Woodley, David T.

AU - Keene, Douglas R.

AU - Atha, Tom

AU - Huang, Yi

AU - Ram, Ramin

AU - Kasahara, Noriyuki

AU - Chen, Mei

PY - 2004/8

Y1 - 2004/8

N2 - Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechanobullous disorders caused by mutations in the gene, COL7A1, that codes for type VII, (anchoring fibril), collagen, which is critical for epidermal-dermal adherence. Most gene therapy approaches have been ex vivo, involving cell culture and culture graft transplantation, which is logistically difficult. To develop a more simplified approach, we engineered a self-inactivating lentiviral vector expressing human type VII collagen and injected this vector intradermally into hairless, immunodeficient mice and into a human DEB composite skin equivalent grafted onto immunodeficient mice. In both situations, the vector transduced dermal cells, which in turn synthesized and exported type VII collagen into the extracellular space. Remarkably, the type VII collagen selectively adhered to and incorporated into the basement membrane zone (BMZ) between the dermis and the epidermis, where it formed anchoring fibril structures. In the case of the DEB skin equivalent, the newly expressed type VII collagen reversed the DEB phenotype characterized by poor epidermal-dermal adherence and anchoring fibril defects. A single lentiviral vector injection provided stable type VII collagen at the BMZ for at least 3 months. These data demonstrate efficient and long-term type VII collagen gene transfer in vivo using direct intradermal injection of an engineered lentiviral vector.

AB - Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechanobullous disorders caused by mutations in the gene, COL7A1, that codes for type VII, (anchoring fibril), collagen, which is critical for epidermal-dermal adherence. Most gene therapy approaches have been ex vivo, involving cell culture and culture graft transplantation, which is logistically difficult. To develop a more simplified approach, we engineered a self-inactivating lentiviral vector expressing human type VII collagen and injected this vector intradermally into hairless, immunodeficient mice and into a human DEB composite skin equivalent grafted onto immunodeficient mice. In both situations, the vector transduced dermal cells, which in turn synthesized and exported type VII collagen into the extracellular space. Remarkably, the type VII collagen selectively adhered to and incorporated into the basement membrane zone (BMZ) between the dermis and the epidermis, where it formed anchoring fibril structures. In the case of the DEB skin equivalent, the newly expressed type VII collagen reversed the DEB phenotype characterized by poor epidermal-dermal adherence and anchoring fibril defects. A single lentiviral vector injection provided stable type VII collagen at the BMZ for at least 3 months. These data demonstrate efficient and long-term type VII collagen gene transfer in vivo using direct intradermal injection of an engineered lentiviral vector.

KW - Anchoring fibril

KW - Basement membrane zone

KW - Gene therapy

KW - Lentivirus

KW - Type VII colagen

UR - http://www.scopus.com/inward/record.url?scp=4344570380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344570380&partnerID=8YFLogxK

U2 - 10.1016/j.ymthe.2004.05.016

DO - 10.1016/j.ymthe.2004.05.016

M3 - Article

C2 - 15294178

AN - SCOPUS:4344570380

VL - 10

SP - 318

EP - 326

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 2

ER -